PharmaCyte Biotech, Inc. (OTCMKTS:PMCB), the clinical stage biotechnology company developing medical treatments for cancer and diabetes using the proprietary “Cell-in-a-Box” technology, has recently drawn traders’ attention again. The company is close to an upcoming clinical trial in locally advanced pancreatic cancer. If the company is able to pass this trial, the stock price will become very violent and make an explosive upward move. Some traders are already buying, have a look at the recent upside movements.
